Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance

Agency ends review of Trump’s ACA mystery order

Your article was successfully shared with the contacts you provided.

Federal regulation reviewers have stopped working on a Centers for Medicare & Medicaid Services proposal for saving the major medical insurance market.

The Office of Information and Regulatory Affairs, part of the Office of Management and Budget, says it concluded its review of the proposal, a draft of an executive order, on Friday.

A copy of the draft, for an executive order with the title “Patient Protection and Affordable Care Act; Market Stabilization,” is not available online.

The draft appears to have something to do with the Affordable Care Act public exchange system. It may include provisions that would affect the off-exchange individual major medical market and the group health market as well as the exchange market.

Related: Trump advisor hears Blues’ ACA market stability proposal

The Senate confirmed Dr. Tom Price, an orthopedic surgeon and longtime House member, to be the new secretary of Health and Human Services on Thursday.

CMS, an arm of the U.S. Department of Health and Human Services, submitted the stabilization executive order draft to OMB on Feb. 1, after Donald Trump had been in president for 11 days but before Price was confirmed.

Representatives from the Chicago-based Blue Cross and Blue Shield Association presented the team working on the executive order with a list of stabilization ideas at a meeting Feb. 6, according to handouts posted in the OMB regulatory review tracking system.

The OMB regulatory reviewers do not give a planned publication date for the proposed order in the tracking system status summary.

The reviewers say they are not sure whether the White House has to put the proposed order through a regulatory flexibility analysis. But the reviews say that they do believe the order could affect the federal government’s relationship with the states, that it would be a major regulatory action, and that it would be economically significant.

The order would not affect national security and it would not create any new, unfunded mandates for other entities, the reviewers say.

The order could affect small businesses, small government jurisdictions and other small organizations, the reviewers say.


Senate prepares to hear Seema Verma, Trump’s ACA boss pick

Senate confirms Price as health secretary as ACA fight nears

We’re on Facebook, are you?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.